Antiplatelet therapy in coronary heart disease.
作者信息
Frishman W H
出版信息
Hosp Pract (Hosp Ed). 1982 May;17(5):73-86. doi: 10.1080/21548331.1982.11702306.
Abstract
摘要
相似文献
1
Antiplatelet therapy in coronary heart disease.
Hosp Pract (Hosp Ed). 1982 May;17(5):73-86. doi: 10.1080/21548331.1982.11702306.
2
Platelets and antiplatelet therapy in ischemic heart disease.
Curr Probl Cardiol. 1986 Feb;11(2):69-136. doi: 10.1016/0146-2806(86)90018-6.
3
Antiplatelet agents: rationale and results.
Clin Haematol. 1983 Feb;12(1):311-54.
4
Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.口服普萘洛尔后心绞痛患者异常血小板聚集性的逆转及运动耐量的变化
Circulation. 1974 Nov;50(5):887-96. doi: 10.1161/01.cir.50.5.887.
5
[Clinical aspects of control in therapy with platelet inhibitors].[血小板抑制剂治疗中的控制临床方面]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):776-82.
6
Thrombocytes and coronary heart disease.
Circulation. 1991 Aug;84(2):936-8. doi: 10.1161/01.cir.84.2.936.
7
Platelet prostacyclin binding in coronary artery disease.冠状动脉疾病中血小板前列环素结合情况
J Am Coll Cardiol. 1986 Aug;8(2):259-66. doi: 10.1016/s0735-1097(86)80037-7.
8
Status of antiplatelet drugs in coronary heart disease.
JAMA. 1979 Jun 15;241(24):2649-51.
9
10
Antiplatelet therapy.抗血小板治疗。
Am Fam Physician. 1981 Oct;24(4):129-34.
Zotero 插件